Showing results (291-300 of 431) with videos related to
Sort By:
Pageof 44
Patient Education and Counseling|January 12, 2017
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologistsSusan Eggly, Lauren M Hamel, Tanina S Foster, et al.JAMA Oncology|July 22, 2016
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian CancerKatharine M Esselen, Angel M Cronin, Kristin Bixel, et al.Breast Cancer Research and Treatment|May 13, 2019
Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapyJennifer Y Sheng, Amanda L Blackford, Aditya Bardia, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013Lyndsay N Harris, Gloria Broadwater, Maysa Abu-Khalaf, et al.The New England Journal of Medicine|March 28, 2019
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast CancerRita S Mehta, William E Barlow, Kathy S Albain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group BMichael P DiGiovanna, David F Stern, Susan Edgerton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancerFrancisco J Esteva, John Glaspy, Said Baidas, et al.Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.Pageof 44